Autoimmune progesterone dermatosis
Linse, R.; Hadlich, J.
Dermatologische Monatschrift 164(9): 656-661
1978
ISSN/ISBN: 0011-9083 PMID: 152213 Document Number: 128254
Document emailed within 1 workday
Related Documents
Stephens, C.J.; Black, M.M. 1989: Perimenstrual eruptions: autoimmune progesterone dermatitis Seminars in Dermatology 8(1): 26-29Steuer, A.B.; Scherl, S.; Ashinoff, R. 2017: Autoimmune Progesterone Dermatitis: a Diagnosis to Consider in a Patient with Cyclical Cutaneous Eruptions Journal of Drugs in Dermatology: Jdd 16(10): 1040-1042
Roche, J.F.; Gosling, J.P. 1977: Control of estrus and progesterone levels in heifers given intravaginal progesterone coils and injections of progesterone and estrogen Journal of Animal Science 44(6): 1026-1029
Anonymous 2000: Progestins, Progesterone Receptor Modulators, and Progesterone Antagonists. Progesterone, progestins and antiprogestins in the next millennium, Jerusalem, Israel, 31 August-3 September, 1999 Steroids 65(10/11): 543-850
Diehl, L.F.; Ketchum, L.H. 1998: Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia Seminars in Oncology 25(1): 80-97
Choe, J.K.; Check, J.H.; Nowroozi, K.; Benveniste, R.; Barnea, E.R. 1992: Serum progesterone and 17-hydroxyprogesterone in the diagnosis of ectopic pregnancies and the value of progesterone replacement in intrauterine pregnancies when serum progesterone levels are low Gynecologic and Obstetric Investigation 34(3): 133-138
Ozaslan, E.; Efe, C.; Akbulut, S.; Purnak, T.; Savas, B.; Erden, E.; Altiparmak, E. 2010: Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis Hepato-Gastroenterology 57(99-100): 441-446
Eto, S.; Fujihira, T. 1988: Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and the therapeutic methods. Organ-specific autoimmune diseases. 1) Autoimmune thyroid diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 894-900
Toivonen, J. 1980: Pituitary and gonadal function during the use of progesterone- or progesterone-estradiol-releasing vaginal rings International Journal of Fertility 25(2): 106-111
Richardson, A.P.; Kim, J.B.; Barnard, G.J.; Collins, W.P.; McCapra, F. 1985: Chemiluminescence immunoassay of plasma progesterone, with progesterone-acridinium ester used as the labeled antigen Clinical Chemistry 31(10): 1664-1668
Dragonas, C.; Maltaris, T.; Binder, H.; Kat, M.; Mueller, A.; Cupisti, S.; Hoffmann, I.; Beckmann, M.W.; Dittrich, R. 2007: Progesterone bioavailability with a progesterone-releasing silicone vaginal ring in IVF candidates European Journal of Medical Research 12(6): 264-267
Wolf, H.; Egert, D.; Maass, H. 1973: Progesterone binding protein and the influence of corticosteroids on the uptake of progesterone by the rat uterus Acta Endocrinologica. Supplementum 173: 68
Pouly, J.L.; Bassil, S.; Frydman, R.; Hédon, B.; Nicollet, B.; Prada, Y.; Antoine, J.M.; Zambrano, R.; Donnez, J. 1997: Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone Contraception Fertilite Sexualite 25(7-8): 596-601
Eremin, A.N.; Metelitsa, D.I. 1989: Catalytic activity of conjugates of peroxidase with progesterone in aqueous and micellar media in the presence of antibodies against progesterone Bioorganicheskaia Khimiia 15(10): 1326-1333
Keltz, M.D.; Stein, D.E.; Berin, I.; Skorupski, J. 2012: Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization Journal of Reproductive Medicine 57(1-2): 9-12
Wu, Z.; Wu, H.; Sun, S.; Wu, H.; Shi, W.; Song, J.; Liu, J.; Zhang, Y.; Bian, F.; Jia, P.; Hou, Y. 2020: Progesterone attenuates Aβ25-35-induced neuronal toxicity by activating the Ras signalling pathway through progesterone receptor membrane component 1 Life Sciences 253: 117360
Allen, W.M.; Ehrenstein, M. 1944: 10-Nor-Progesterone, a Physiologically Active Lower Homolog of Progesterone Science 100(2594): 251-252
Conley, C.L. 1981: Immunologic precursors of autoimmune hematologic disorders. Autoimmune hematologic disorders. Autoimmune hemolytic anemia and thrombocytopenic purpura Johns Hopkins Medical Journal 149(3): 101-109
Botella, J.; Duranti, E.; Viader, V.; Duc, I.; Delansorne, R.; Paris, J. 1995: Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells Journal of Steroid Biochemistry and Molecular Biology 55(1): 77-84
Berger, U.; Wilson, P.; Thethi, S.; McClelland, R.A.; Greene, G.L.; Coombes, R.C. 1989: Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors Cancer Research 49(18): 5176-5179